Date: Tuesday 19 April
Location: St. Mary’s Stadium – Britannia Road Southampton, Hampshire SO14 5FP GB – View Map
Time: 9:00am – 5:00pm
About the event:
Big Data in healthcare is being used to cure disease, improve quality of life, avoid preventable deaths and more importantly plan primary prevention strategies. With the UK population increasing and all of us living longer, through initiatives such as the Vanguards, models of care are rapidly changing, and many of the decisions behind those changes are being driven by data.
This Big Data conference, chaired by Richard Samuel, (Fareham and Gosport, South-Eastern Hants CEO) will provide an overview of Big Data from experts within the field, as well as practical examples of how Big Data is being used to improve the way that we deliver services. A Big Data expo will be accessible throughout the day and in the afternoon a variety of plenary sessions will gather feedback from participants to help shape future actions.
To register: Click here
If you have any questions or queries regarding the event or any specific access needs please do not hesitate to contact Katie Cheeseman – Digital Health Programme Manager katie.cheeseman@wessexahsn.net











REF 2029 Sector Survey: Have Your Say
BU methods paper reached 2,500 reads
UKCGE Recognised Research Supervision Programme: Applications Close 19 October
Dr. Orlanda Harvey interviewed as expert
Dr. Paul Whittington attends Technology and the SEND Reforms Roundtable in the House of Commons
Dr. Paul Whittington joins Bett 2026 DfE Assistive Technology Roundtable
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease